These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15987375)

  • 1. Independent association of massive blood loss with mortality in cardiac surgery.
    van de Watering L; Brand A
    Transfusion; 2005 Jul; 45(7):1235; author reply 1235-6. PubMed ID: 15987375
    [No Abstract]   [Full Text] [Related]  

  • 2. The independent association of massive blood loss with mortality in cardiac surgery.
    Karkouti K; Wijeysundera DN; Yau TM; Beattie WS; Abdelnaem E; McCluskey SA; Ghannam M; Yeo E; Djaiani G; Karski J
    Transfusion; 2004 Oct; 44(10):1453-62. PubMed ID: 15383018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials.
    Takagi H; Manabe H; Kawai N; Goto SN; Umemoto T
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):98-101. PubMed ID: 19380335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-of-the-art blood management in cardiac surgery.
    Samolyk KA
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):118-21. PubMed ID: 19622533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding as a predictor of mortality risk.
    Rao SV
    Rev Cardiovasc Med; 2006; 7 Suppl 3():S12-8. PubMed ID: 17224879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
    Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative sum curves and their prediction limits.
    Grunkemeier GL; Jin R; Wu Y
    Ann Thorac Surg; 2009 Feb; 87(2):361-4. PubMed ID: 19161738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Present status of preparatory measures for massive hemorrhage and emergency blood transfusion in regional hospitals with an accredited department of anesthesiology in 2006].
    Irita K; Inada E; Yoshimura H; Warabi K; Tsuzaki K; Inaba S; Handa M; Uemura T; Kino S; Mashiko K; Yano T; Kamei Y; Kubo T
    Masui; 2009 Jan; 58(1):109-23. PubMed ID: 19175027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmatic blood conservation in cardiac surgery.
    Ralley FE
    Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):242-6. PubMed ID: 18270185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 12. Bloodless cardiac surgery: not just possible, but preferable.
    Putney LJ
    Crit Care Nurs Q; 2007; 30(3):263-70. PubMed ID: 17579310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eComment: Re: Multi-modality blood conservation strategy in open heart surgery: an audit.
    Bockeria LA; Grigoryants RG
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):482-3. PubMed ID: 19687048
    [No Abstract]   [Full Text] [Related]  

  • 14. Variability and predictability of large-volume red blood cell transfusion in cardiac surgery: a multicenter study.
    Karkouti K; Wijeysundera DN; Beattie WS; Callum JL; Cheng D; Dupuis JY; Kent B; Mazer D; Rubens FD; Sawchuk C; Yau TM;
    Transfusion; 2007 Nov; 47(11):2081-8. PubMed ID: 17958538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An empirically based tool for analyzing mortality associated with congenital heart surgery.
    O'Brien SM; Clarke DR; Jacobs JP; Jacobs ML; Lacour-Gayet FG; Pizarro C; Welke KF; Maruszewski B; Tobota Z; Miller WJ; Hamilton L; Peterson ED; Mavroudis C; Edwards FH
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1139-53. PubMed ID: 19837218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cardiopulmonary bypass circuit reduction and residual volume salvage on allogeneic transfusion requirements in infants undergoing cardiac surgery.
    Golab HD; Takkenberg JJ; van Gerner-Weelink GL; Wijers MJ; Scohy TV; de Jong PL; Bogers AJ
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):335-9. PubMed ID: 17669859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of blood loss on outcome after liver resection.
    de Boer MT; Molenaar IQ; Porte RJ
    Dig Surg; 2007; 24(4):259-64. PubMed ID: 17657150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of independent risk-factors for long-term mortality prediction after cardiac surgery.
    Toumpoulis IK; Anagnostopoulos CE; Ioannidis JP; Toumpoulis SK; Chamogeorgakis T; Swistel DG; Derose JJ
    Eur J Clin Invest; 2006 Sep; 36(9):599-607. PubMed ID: 16919041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications related to blood transfusion in surgical patients: data from the French national survey on anesthesia-related deaths.
    Auroy Y; Lienhart A; Péquignot F; Benhamou D
    Transfusion; 2007 Aug; 47(2 Suppl):184S-189S; discussion 201S. PubMed ID: 17651348
    [No Abstract]   [Full Text] [Related]  

  • 20. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery.
    Basran S; Frumento RJ; Cohen A; Lee S; Du Y; Nishanian E; Kaplan HS; Stafford-Smith M; Bennett-Guerrero E
    Anesth Analg; 2006 Jul; 103(1):15-20, table of contents. PubMed ID: 16790618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.